Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HaystackAnalytics commercially provides next-generation sequencing (NGS)-based, culture-free infectious disease diagnostics (e.g., Universal Infectious Diseases Test and TB-ONE-NGS) that identify >1200 pathogens and antibiotic resistance genes with turnaround times under 12 hours; products are deployed with Indian hospitals and diagnostic labs, have been recognized by BIRAC and launched at a national level, and the company holds NABL accreditation and ISO/CE-IVD certifications for its genomics-based diagnostics.[1][2][6][11]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HaystackAnalytics.